[go: up one dir, main page]

ZA958708B - Pharmaceutical composition for prophylaxis and treatment of Type I allergic diseases - Google Patents

Pharmaceutical composition for prophylaxis and treatment of Type I allergic diseases

Info

Publication number
ZA958708B
ZA958708B ZA958708A ZA958708A ZA958708B ZA 958708 B ZA958708 B ZA 958708B ZA 958708 A ZA958708 A ZA 958708A ZA 958708 A ZA958708 A ZA 958708A ZA 958708 B ZA958708 B ZA 958708B
Authority
ZA
South Africa
Prior art keywords
branched
linear
allergic diseases
type
prophylaxis
Prior art date
Application number
ZA958708A
Other languages
English (en)
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of ZA958708B publication Critical patent/ZA958708B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA958708A 1994-10-17 1995-10-16 Pharmaceutical composition for prophylaxis and treatment of Type I allergic diseases ZA958708B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17

Publications (1)

Publication Number Publication Date
ZA958708B true ZA958708B (en) 1996-05-14

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958708A ZA958708B (en) 1994-10-17 1995-10-16 Pharmaceutical composition for prophylaxis and treatment of Type I allergic diseases

Country Status (19)

Country Link
US (1) US5814649A (xx)
EP (1) EP0787491B1 (xx)
KR (1) KR100365064B1 (xx)
AT (1) ATE194912T1 (xx)
AU (1) AU695907B2 (xx)
CA (1) CA2202904C (xx)
DE (1) DE69518159T2 (xx)
DK (1) DK0787491T3 (xx)
ES (1) ES2148561T3 (xx)
FI (1) FI971584A7 (xx)
GR (1) GR3034413T3 (xx)
HU (1) HU222888B1 (xx)
IL (1) IL115617A (xx)
NO (1) NO315928B1 (xx)
NZ (1) NZ293691A (xx)
PT (1) PT787491E (xx)
TW (1) TW429146B (xx)
WO (1) WO1996011682A1 (xx)
ZA (1) ZA958708B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT903345E (pt) * 1997-08-08 2001-01-31 Aventis Pharma Gmbh Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida
JP4388228B2 (ja) 1998-02-19 2009-12-24 興和株式会社 環状アミド化合物
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2001051008A2 (en) * 2000-01-07 2001-07-19 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
AU2001236361A1 (en) * 2000-10-20 2002-05-06 Parker Hughes Institute Treatment of asthma with lfm analogues
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
CN104666272A (zh) 2009-09-18 2015-06-03 赛诺菲 稳定性提高的(z)-2-氰基-3-羟基-丁-2-烯酸-(4’-三氟甲基苯基)-酰胺片剂制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (xx) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
GR3034413T3 (en) 2000-12-29
ATE194912T1 (de) 2000-08-15
DK0787491T3 (da) 2000-10-16
AU695907B2 (en) 1998-08-27
KR970706811A (ko) 1997-12-01
NZ293691A (en) 1999-07-29
FI971584L (fi) 1997-04-15
IL115617A (en) 1999-11-30
IL115617A0 (en) 1996-01-19
CA2202904A1 (en) 1996-04-25
HUT77135A (hu) 1998-03-02
AU3618695A (en) 1996-05-06
KR100365064B1 (ko) 2003-04-11
CA2202904C (en) 2006-12-19
EP0787491B1 (en) 2000-07-26
FI971584A0 (fi) 1997-04-15
EP0787491A4 (en) 1998-09-30
WO1996011682A1 (en) 1996-04-25
PT787491E (pt) 2000-11-30
TW429146B (en) 2001-04-11
US5814649A (en) 1998-09-29
NO971743D0 (no) 1997-04-16
HU222888B1 (hu) 2003-12-29
ES2148561T3 (es) 2000-10-16
NO315928B1 (no) 2003-11-17
DE69518159T2 (de) 2002-01-03
DE69518159D1 (de) 2000-08-31
FI971584A7 (fi) 1997-04-15
EP0787491A1 (en) 1997-08-06
NO971743L (no) 1997-04-16

Similar Documents

Publication Publication Date Title
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
AU695907B2 (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69614508D1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
AU1925500A (en) 4&#39;-substituted-4&#39;,5&#39;-dihydropsoralens and therapeutical uses thereof
PH30180A (en) Leustroducsin h its preparation and its therapeutic use
MX9604072A (es) Derivados de oxazolidinona y composiciones farmaceuticas que los contienen.